Rothia is a genus of Gram-positive, facultatively anaerobic bacteria in the family Micrococcaceae (phylum Actinobacteria). The most commonly identified species in microbiome studies are Rothia dentocariosa and Rothia mucilaginosa, both of which are primary inhabitants of the oral cavity — found in saliva, dental plaque, and the pharynx. Rothia is a normal commensal of the human mouth but can become pathogenic in immunocompromised hosts.
From a WikiBiome perspective, Rothia is significant because it bridges oral and systemic health through two mechanisms: its nitrate-reducing activity influences systemic nitric oxide biology, and its detection in the gut, peritoneum, or duodenum often signals oral-gut microbial translocation — a hallmark of disrupted mucosal barriers.
Metal Dependencies
- Iron: Required for cytochrome-based electron transport in aerobic and anaerobic respiration. Rothia species possess siderophore uptake systems for iron acquisition.
- Manganese: R. mucilaginosa uses manganese-dependent superoxide dismutase (MnSOD) for oxidative stress defense, enabling survival in oxygen-variable environments from the aerobic oral cavity to the microaerobic gut.
Key Enzymes and Virulence Factors
- Nitrate reductase: Rothia is among the key oral nitrate-reducing bacteria that convert dietary nitrate (from leafy greens) to nitrite, which is subsequently reduced to nitric oxide (NO) in the stomach. This enterosalivary nitrate-nitrite-NO pathway contributes to blood pressure regulation and antimicrobial defense. Its disruption (e.g., by antiseptic mouthwash) has been linked to hypertension.
- Urease: Some Rothia strains produce urease, enabling survival in acidic environments and contributing to nitrogen cycling in the oral cavity.
- Biofilm formation: Rothia participates in multi-species oral biofilms and can contribute to dental caries when ecological balance is disrupted.
Ecological Role
Rothia occupies a unique position as an oral ecosystem engineer with systemic reach:
- In the healthy oral cavity, Rothia is a dominant member of the supragingival plaque community and a key partner in the nitrate reduction cascade.
- Its detection in gut, duodenal, or peritoneal samples is often a marker of oral-gut translocation — indicating that oral bacteria have survived gastric transit (often due to PPI use or achlorhydria) and colonized distal sites.
- In Crohn's disease, Rothia was enriched alongside Fusobacterium, Streptococcus, and Collinsella in CD-specific metagenomics (kang 2023 diagnosis crohns uc microbiome, cross-sectional).
- Thonzonium bromide, a repurposed drug for dental caries, specifically disrupted Rothia in oral swabs of rodent models, demonstrating its central role in oral biofilm ecology (simon soro 2021 thonzonium bromide oral gut microbiomes, animal-model).
Conditions Associated
Enriched in:
- Crohn's disease: Enriched in CD alongside other oral-origin taxa; part of the facultative anaerobe expansion pattern seen in IBD (kang 2023 diagnosis crohns uc microbiome, cross-sectional).
- Cerebral palsy with epilepsy: Significantly enriched (0.62 +/- 0.82%) in CPE children alongside Streptococcus, Veillonella, and other oral-origin taxa; paradoxical high diversity reflecting pathobiont expansion (huang 2019 gut microbiota cerebral palsy epilepsy, cross-sectional).
- GERD/NERD: Rothia sp. was a discriminatory taxon for non-erosive reflux disease (NERD) by LEfSe analysis (sugihartono 2022 gastric microbiota hpylori gerd, cross-sectional).
- Pancreatic cancer: Found in duodenal microbiota of PC patients alongside Bifidobacterium, Enterococcus, and Neisseria (pourali 2024 microbiome biomarker therapeutic target pancreatic cancer, expert-opinion).
Depleted in:
- Endometriosis: Rothia significantly decreased in peritoneal fluid extracellular vesicles from women with advanced endometriosis, alongside Propionibacterium and Actinomyces (lee 2021 peritoneal microbiota ovarian endometrioma, cross-sectional).
Protective associations:
- Chronic kidney disease: Mendelian randomization identifies Rothia species as causally protective against elevated urinary albumin-to-creatinine ratio (UACR) (IVW OR = 0.99, 95% CI 0.99-1, p = 0.03), possibly by inhibiting inflammatory pathways that damage the glomerular filtration barrier (liu 2026 oral microbiome ckd mendelian randomization, quasi-experimental).
Oral biomarker:
- Colorectal cancer: Rothia dentocariosa and Rothia mucilaginosa were among the top 10 CRC-associated salivary microbes in an Iranian cohort, present in CRC patients but absent from healthy controls. This supports oral microbiome-based cancer screening (rezasoltani 2024 16s oral fecal microbiota crc iran, cross-sectional).
Key Studies
| Study | Finding | Evidence Level |
|---|---|---|
| liu 2026 oral microbiome ckd mendelian randomization | Causally protective against elevated UACR in CKD | Quasi-experimental |
| rezasoltani 2024 16s oral fecal microbiota crc iran | R. dentocariosa and R. mucilaginosa as salivary CRC biomarkers | Cross-sectional |
| kang 2023 diagnosis crohns uc microbiome | Enriched in Crohn's disease metagenomics | Cross-sectional |
| lee 2021 peritoneal microbiota ovarian endometrioma | Depleted in peritoneal fluid in endometriosis | Cross-sectional |
| simon soro 2021 thonzonium bromide oral gut microbiomes | Disrupted by thonzonium bromide in oral biofilm | Animal model |
Cross-References
- streptococcus — co-occurring oral-translocation genus
- veillonella — co-occurring oral commensal; co-enriched in CPE
- haemophilus — fellow oral-gut bridging organism
- crohns disease — oral-origin taxa enrichment
- endometriosis — peritoneal microbiota depletion
- chronic kidney disease — oral-kidney axis protection
- colorectal cancer — salivary biomarker potential
- nitric oxide — nitrate reduction pathway